Raloxifene Treatment Is Associated With Increased Serum Estradiol and Decreased Bone Remodeling in Healthy Middle‐Aged Men With Low Sex Hormone Levels

  title={Raloxifene Treatment Is Associated With Increased Serum Estradiol and Decreased Bone Remodeling in Healthy Middle‐Aged Men With Low Sex Hormone Levels},
  author={B. Uebelhart and F. Herrmann and I. Pavo and M. Draper and R. Rizzoli},
  journal={Journal of Bone and Mineral Research},
In healthy middle‐aged men, raloxifene treatment was associated with increased serum estradiol and decreased biochemical markers of bone turnover in subjects with estradiol levels below a threshold of 101.8 pM. 
47 Citations
Estrogen in men: effects on bone accrual, maintenance and prevention of bone loss
  • 5
Effects of the SERM raloxifene on calcium and phosphate metabolism in healthy middle-aged men.
  • B. Uebelhart, F. Herrmann, R. Rizzoli
  • Medicine
  • Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases
  • 2009
  • 9
  • PDF
Estrogen and bone: insights from estrogen-resistant, aromatase-deficient, and normal men.
  • 42
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy
  • 13
  • PDF
New Insights Into Androgen and Estrogen Receptor Regulation of the Male Skeleton
  • S. Khosla
  • Biology, Medicine
  • Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 2015
  • 26
The use of selective estrogen receptor modulators on bone health in men
  • 7
Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-β3 content in bone of female mice.
  • 6


Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men
  • 102
  • Highly Influential
Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.
  • 447
Raloxifene: Recent information on skeletal and non-skeletal effects
  • 13
A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
  • 337
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men.
  • 655
  • PDF
The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men.
  • 109
  • PDF
Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study.
  • 219
  • PDF
Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.
  • 479
  • PDF
Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study.
  • 270
  • PDF